WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2013050378) GLP-1 AGONIST FOR USE IN THE TREATMENT OF STENOSIS OR/AND OBSTRUCTION IN THE BILIARY TRACT
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2013/050378    International Application No.:    PCT/EP2012/069483
Publication Date: 11.04.2013 International Filing Date: 02.10.2012
Chapter 2 Demand Filed:    18.03.2013    
IPC:
A61K 38/26 (2006.01)
Applicants: SANOFI-AVENTIS DEUTSCHLAND GMBH [DE/DE]; Brüningstrasse 50 65929 Frankfurt (DE)
Inventors: STECHL, Jens; (DE).
NOWOTNY, Irene; (DE).
PFEIFFER, Claudia; (DE).
PINQUIER, Jean-Louis; (FR).
MSIHID, Jerome; (FR)
Agent: WEISS, Wolfgang; Weickmann & Weickmann Postfach 860 820 81635 München (DE)
Priority Data:
11183863.7 04.10.2011 EP
Title (EN) GLP-1 AGONIST FOR USE IN THE TREATMENT OF STENOSIS OR/AND OBSTRUCTION IN THE BILIARY TRACT
(FR) AGONISTE DU GLP-1 POUR L'UTILISATION DANS LE TRAITEMENT DE LA STÉNOSE ET/OU DE L'OBSTRUCTION DANS LE TRACTUS BILIAIRE
Abstract: front page image
(EN)The present invention relates to a pharmaceutical composition for use in the treatment of a disease or condition, wherein said disease or condition is associated (a) stenosis or/and obstruction located in the biliary tract, or/and (b) biliary dyskinesia, said composition comprising at least one GLP-1 agonist and optionally a pharmaceutically acceptable carrier, diluent or/and auxiliary substance.
(FR)La présente invention concerne une composition pharmaceutique pour l'utilisation dans le traitement d'une maladie ou d'une pathologie, ladite maladie ou pathologie étant associée à (a) la sténose et/ou l'obstruction localisée dans le tractus biliaire, et/ou (b) la dyskinésie biliaire, ladite composition comprenant au moins un agoniste du GLP-1 et facultativement un support, un diluant et/ou une substance auxiliaire pharmaceutiquement acceptables.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)